Implantable Drug Delivery Systems Market Size, Share, Opportunities And Trends By Type (Non-Degradable, Biodegradable), By Mechanism (Diffusion, Magnetic, Chemical, Osmotic, Others), By Application (Oncology, Cardiovascular, Auto-Immune Disease, Others) And Geography - Forecasts From 2019 To 2024

Implantable drug delivery systems are placed under the skin to release drugs and fluids directly into the bloodstream without the repeated insertion of needles. The implantable therapeutic systems are mainly approached for the long term, continuous drug administration and controlled release of the medication. The system is well suited for the drug delivery requirements of insulin, steroids, chemotherapeutic drugs, heparin, etc. This system is more steady, effective, safe and reliable than other drug delivery system. The market is expected to show significant growth during the forecast period owing to the rising awareness among the population regarding the availability of high quality and safer products. Reduced side effects and on-site delivery provided by Implantable Drug Delivery systems will also boost the growth of the market. However, the need for microsurgery to implant the system and stringent regulatory requirements for the implantable drug delivery systems might restrain the growth of the market during the given time frame. Geographically, North America is expected to hold a significant market share owing to the increasing investment in R&D. Asia-Pacific is also anticipated to be a prominent region on account of the rising healthcare industry.

• DRIVERS
• Growing preference for minimally invasive procedures.
• Growing prevalence of chronic diseases.

• RESTRAINTS
• Strict government regulations.

• INDUSTRY UPDATE
• In April 2019, Boston Scientific Corporation received U.S. Food and Drug Administration (FDA) approval for the LOTUS Edge Aortic Valve System.
• In July 2018, Boston Scientific Corporation acquired Claret Medical Inc.,

The major players profiled in the Implantable Drug Delivery Systems market include Microchips Biotech, Inc., DSM, TissueGen, SFC Fluidics, Inc., Medtronic, 3M’s Health Care, Boston Scientific Corporation, Bausch and Lomb, PSivida, Delpor Inc.

Segmentation

The Implantable Drug Delivery Systems markethas been analyzed through the following segments:

• By Type
  • Non-Degradable Systems
  • Biodegradable systems

• By Mechanism
  • Diffusion
  • Magnetic
  • Chemical
  • Osmotic
  • Others

• By Application
  • Oncology
  • Cardiovascular
  • Auto Immune disease
  • Others

• By Geography
  • North America
    • USA
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Spain
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • Israel
    • Others
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Others

Target audience

• Manufacturers
• Suppliers
• Distributors
• Service Providers
• Government Agencies
• Research Organizations
• Consultants

---